Literature DB >> 7541581

Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinoma.

V A Miller1, V Reuter, H I Scher.   

Abstract

We describe a 67-year-old man with a history of Stage B1 adenocarcinoma of the prostate who was treated with iodine-125 implantation in 1985. His prostate-specific antigen values subsequently increased in conjunction with an intraprostatic recurrence. Biopsy revealed primary squamous cell carcinoma arising in the prostate; no adenocarcinomatous elements were noted.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7541581     DOI： 10.1016/S0090-4295(99)80174-5

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  5 in total

Review 1.  Diagnostic dilemmas of squamous differentiation in prostate carcinoma case report and review of the literature.

Authors:  Nicoleta C Arva; Kasturi Das
Journal:  Diagn Pathol       Date:  2011-05-31       Impact factor: 2.644

2.  Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation.

Authors:  Fernando Munoz; Pierfrancesco Franco; Patrizia Ciammella; Mario Clerico; Mauro Giudici; Andrea Riccardo Filippi; Umberto Ricardi
Journal:  Radiat Oncol       Date:  2007-04-03       Impact factor: 3.481

3.  Squamous cell carcinoma of the prostate following treatment with an LHRH-agonist: a rare case of transformation of adenocarcinoma of the prostate.

Authors:  Zubair Al-Qassim; Aza Mohammed; David Payne; Philippa Jane Stocks; Zeb Khan
Journal:  Cent European J Urol       Date:  2014-04-17

4.  Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma.

Authors:  Toru Matsugasumi; Hiroyuki Nakanishi; Tomohiro Yokota; Takumi Shiraishi; Osamu Ukimura
Journal:  IJU Case Rep       Date:  2020-04-20

5.  Squamous cell transformation and EGFR T790M mutation as acquired resistance mechanisms in a patient with lung adenocarcinoma treated with a tyrosine kinase inhibitor: A case report.

Authors:  Rossella Bruno; Agnese Proietti; Greta Alì; Gianfranco Puppo; Alessandro Ribechini; Antonio Chella; Gabriella Fontanini
Journal:  Oncol Lett       Date:  2017-09-08       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.